Clinical Trials, Research and Development
July 11, 2023
Via: Biopharm InternationalFDA recently granted full, or traditional, approval to Eisai Pharmaceutical’s Alzheimer’s treatment Leqembi, converting an earlier conditional approval status with further data from a multi-regional study of nearly 1800 patients. Results indicated that the drug slows the rate of cognitive […]
July 11, 2024
July 19, 2024
July 11, 2024